Companion files · The Private Markets Career Guides

The Healthcare Private Equity Investor

Physician Practice Roll-Ups, MSO Structures, Stark and Anti-Kickback Rules, State Transaction Laws, Due Diligence and Returns.

These are the companion files of the book. One workbook rebuilds Fenwold Dermatology Partners, the fictional platform of the case: 18 clinics, 30 dermatologists and 16 advanced practice providers, studied by Wexcombe Capital Partners at $170.00 million. It follows the practice accounts and the compensation scale-back, the quality of earnings, the MSO and the professional corporation, six add-ons, the projection from 2027 to 2031, the debt and its covenant, the returns, the downside cases and the physicians' proceeds. A toolkit holds the checklists of Appendix B in an editable form.

The workbook, the toolkit and the read-me, in one archive101 KB

The archive holds the workbook, the toolkit and 00_START_HERE.md. No macros, no circular references, no external links. The workbook recalculates in Excel, LibreOffice or Google Sheets.

The files

Three numbers to reproduce first

The scale-backThe dermatologists' pay falls from 55 to 45 percent of their collections: $4.80 million a year becomes EBITDA, $59.87 million of value at the entry multiple
The price$170.00 million: 12.47x underwritten EBITDA of $13.63 million; unlevered IRR 13.71 percent, levered 15.76 percent and 2.03x on the equity
The add-onsSix practices bought at 7.0x for $51.90 million of cash; without them the same platform returns 7.36 percent

The files are provided as they are, without warranty of any kind. The model is illustrative: Wexcombe Capital Partners, its Fund, Fenwold Dermatology Partners, the founding physicians and the add-ons are fictional, and collections, pay shares, costs, prices, multiples, rates and dates are the book’s assumptions, not the terms of any real practice, payer or lender, the quote of any real market or a forecast. Nothing here is legal, regulatory, tax, accounting or investment advice.